Printer Friendly
The Free Library
14,497,195 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Bilirubin: both villain and hero? (Biomedicine).


Bilirubin Bilirubin

The predominant orange pigment of bile. It is the major metabolic breakdown product of heme, the prosthetic group of hemoglobin in red blood cells, and other chromoproteins such as myoglobin, cytochrome, and catalase.
, the bile pigment that yellows the skin of babies born with jaundice jaundice (jôn`dĭs, jän`–), abnormal condition in which the body fluids and tissues, particularly the skin and eyes, take on a yellowish color as a result of an excess of bilirubin. , is generally considered a toxic molecule. According to a new study, however, bilirubin may actually protect cells from dangerous oxygen-containing molecules called free radicals.

Bilirubin forms during the breakdown of hemoglobin, the oxygen-carrying protein in blood cells, and can build up to high concentrations in the blood. Several lines of evidence indicate that bilirubin is toxic, but why then is there a specific enzyme that converts the seemingly harmless molecule known as bilverdin into bilirubin?

Scientists puzzled by this question have unearthed Unearthed is the name of a Triple J project to find and "dig up" (hence the name) hidden talent in regional Australia.

Unearthed has had three incarnations - they first visited each region of Australia where Triple J had a transmitter - 41 regions in all.
 data suggesting that bilirubin, when present at the right concentration, is helpful instead of harmful. A research team headed by Solomon H. Snyder Dr. Solomon H. Snyder (born December 26, 1938) is an American neuroscientist.

Snyder graduated from Georgetown University in 1958 and Georgetown Medical School in 1962.
 of Johns Hopkins University School of Medicine The Johns Hopkins University School of Medicine, located in Baltimore, Maryland, USA, is a highly regarded medical school and biomedical research institute in the United States.  in Baltimore reports that bilirubin protects brain cells growing in lab dishes from the damage typically caused by hydrogen peroxide, a free radical.

The scientists compared normal cells with ones in which the bilirubin-making enzyme was inhibited. The normal cells were able to survive a dose of hydrogen peroxide 10,000 times greater than the lethal dose for the bilirubin-deprived cells. The investigators report their findings in an upcoming Proceedings of the National Academy of Sciences The Proceedings of the National Academy of Sciences of the United States of America, usually referred to as PNAS, is the official journal of the United States National Academy of Sciences. .

Snyder and his colleagues also garnered evidence for a mechanism by which bilirubin, which is altered when it defuses free radicals, is recycled back into its original form. This reuse amplifies its protective powers. A protective role for bilirubin may explain previous findings that have linked low blood concentrations of the molecule to cancer, heart attacks, and other diseases, the scientists note.
COPYRIGHT 2002 Science Service, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:molecule that converts bilverdin into bilirubin leads to questions about function of bilirubin in protecting cells from free radicals
Author:Travis, John
Publication:Science News
Article Type:Brief Article
Date:Dec 14, 2002
Words:263
Previous Article:Sizing up small stars. (Astronomy).(size of Proxima Centauri star measured)(Brief Article)
Next Article:Zapping bone brings relief from tumor pain. (Cancer).(use of radio waves)(Brief Article)
Topics:



Related Articles
Bilirubin: bad, yet good?
New therapy blocks newborn jaundice.
Vitamin C protects blood from radicals.
Pigment protects heart's arteries. (bilirubin in the bloodstream may protect against heart disease)(Biomedicine)(Brief Article)
The Clinic.(Column)
Coexisting Gilbert's syndrome and sickle cell disease.
Heroes and bilirubins. (Letters).(Letter to the Editor)
Haynes, Melinda. Chalktown.(Book Review)
Ono Pharmaceutical Announces Changes in Investigational AIDS Drug Development Program.
Ono Pharmaceutical Announces Termination of Patient Enrollment for Phase III Clinical Trial of Investigational AIDS Drug.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles